arrow
N

Nuria Labiod

centro nacional de microbiología
H指数:10
被引数:511

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated human seroprevalence study and entomological surveillance of West Nile virus in Cádiz, Spain

西葡加的斯地区西尼罗病毒的血清流行病学调查与媒介监测综合研究

2026-10-210
OAAI
Oral immunization with virus-like particles elicits Ebola virus-specific humoral and cellular immune responses in mice

口服病毒样颗粒免疫在小鼠中诱导埃博拉病毒特异的体液和细胞免疫应答

Vaccine
IF3.5
2026-05-290
OAAI
Molecular Epidemiology and Surveillance of Imported Dengue in Travellers returning to Spain, 2022-2024.

2022-2024年西班牙回国旅行者输入性登革热的分子流行病学与监测

2026-05-040
OAAI
MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses
2024-08-290
OAAI
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2

双特异性中和抗体介导的树突状细胞介导的交叉引发可增强细胞毒性T细胞反应并保护小鼠免受SARS-CoV-2

2023-10-200
OAAI
Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19-Convalescent Individuals

在幼稚和COVID-19-Convalescent个体中接种BNT162b2疫苗后8个月对SARS-CoV-2变体的中和反应

2021-12-2813
OAAI
Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naive and COVID-19-Convalescent Individuals

BNT162b2的初次加强疫苗接种可在幼稚和COVID-19-Convalescent个体中诱导针对SARS-CoV-2变体的高中和活性

2021-09-247
OAAI